What is Lila Sciences?
Founded in 2023 and headquartered in Cambridge, Massachusetts, Lila Sciences is at the forefront of developing the world's first scientific superintelligence platform. This platform, known as the AI Science Factory (AISF), uniquely combines generative AI with autonomous laboratory infrastructure. AISF is designed to autonomously execute, observe, and iterate on scientific experiments across life sciences, chemistry, and materials science, operating at a scale and speed previously unattainable by human capacity alone. The company has already demonstrated promising early results, including the discovery of novel antibodies, genetic medicine constructs, green hydrogen catalysts, and advanced carbon capture materials, positioning it as a key innovator in the venture capital-backed scientific AI sector.
How much funding has Lila Sciences raised?
Lila Sciences has raised a total of $435M across 2 funding rounds:
Angel/Seed
$200M
Series A
$235M
Angel/Seed (2025): $200M with participation from March Capital, Blue Horizon Advisors, Flagship Pioneering, General Catalyst, Ark Venture Fund, Altitude Life Science Ventures, and Modi Ventures
Series A (2025): $235M led by Collective Global and Braidwell
Key Investors in Lila Sciences
Collective Global
Collective Global is an aligned investment collective formed by a global team of leading allocators, partnering with elite venture managers to establish a better way to invest in venture and growth. They aim to provide strategic investment solutions tailored to sophisticated clients looking for innovative opportunities.
Braidwell
Braidwell seeks to serve the people and organizations that transform human health by providing flexible capital and thoughtful partnership to companies at all stages of development, across public, private, and structured capital markets.
March Capital
March Capital is a growth-stage venture firm that specializes in investing in enterprise technology companies with established product-market fit, aiming to scale them into mission-critical global platforms. The firm targets large market opportunities and focuses on creating category leaders.
What's next for Lila Sciences?
The substantial enterprise-level funding Lila Sciences has garnered, particularly the recent major strategic investment, signals a critical growth phase for the company. This capital is expected to fuel the planned expansion into San Francisco and London, alongside further development and scaling of its AI Science Factory platform. With a leadership team comprising CEO Geoffrey von Maltzahn and Chief Scientist George Church, Lila Sciences is poised to accelerate its impact across multiple scientific disciplines, aiming to transform the pace and scope of innovation in drug discovery, materials science, and beyond. The company's trajectory suggests a focus on solidifying its market leadership and translating its AI-driven discoveries into tangible real-world applications.
See full Lila Sciences company page
